{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:46:52Z","timestamp":1781945212665,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12072-025-10819-1","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T23:13:37Z","timestamp":1744067617000},"page":"174-185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Platelet slope and long-term clinical outcomes in children and adults with Fontan-associated liver disease"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-9378","authenticated-orcid":false,"given":"Chaowapong","family":"Jarasvaraparn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rodenbarger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Thoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry Wayne","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean P.","family":"Molleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"10819_CR1","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1161\/CIR.0000000000000696","volume":"140","author":"J Rychik","year":"2019","unstructured":"Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH, et al. Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation. 2019;140:e234\u2013e284","journal-title":"Circulation"},{"key":"10819_CR2","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1007\/s00330-016-4614-x","volume":"27","author":"FW DiPaola","year":"2017","unstructured":"DiPaola FW, Schumacher KR, Goldberg CS, Friedland-Little J, Parameswaran A, Dillman JR. Effect of Fontan operation on liver stiffness in children with single ventricle physiology. Eur Radiol. 2017;27:2434\u20132442","journal-title":"Eur Radiol"},{"key":"10819_CR3","doi-asserted-by":"publisher","first-page":"100362","DOI":"10.1016\/j.jhepr.2021.100362","volume":"3","author":"J Emamaullee","year":"2021","unstructured":"Emamaullee J, Khan S, Weaver C, Goldbeck C, Yanni G, Kohli R, et al. Non-invasive biomarkers of Fontan-associated liver disease. JHEP Reports. 2021;3:100362","journal-title":"JHEP Reports"},{"key":"10819_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.dld.2023.12.017","volume":"56","author":"C Jarasvaraparn","year":"2024","unstructured":"Jarasvaraparn C, Thoe J, Rodenbarger A, Masuoka H, Payne RM, Markham LW, et al. Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults. Digestive and Liver Disease. 2024;56:1335\u20131342","journal-title":"Digestive and Liver Disease"},{"key":"10819_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/eurheartj\/ehy620","volume":"40","author":"ID Munsterman","year":"2019","unstructured":"Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, et al. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J. 2019;40:1057\u20131068","journal-title":"Eur Heart J"},{"key":"10819_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2036.2008.03674.x","volume":"27","author":"P Witters","year":"2008","unstructured":"Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, et al. Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017\u20131029","journal-title":"Aliment Pharmacol Ther"},{"key":"10819_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000\u20131007","journal-title":"J Hepatol"},{"key":"10819_CR8","doi-asserted-by":"publisher","first-page":"e2877","DOI":"10.1097\/MD.0000000000002877","volume":"95","author":"Y Peng","year":"2016","unstructured":"Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine. 2016;95:e2877","journal-title":"Medicine"},{"key":"10819_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/lt.20906","volume":"13","author":"DM Heuman","year":"2007","unstructured":"Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, et al. MELD-XI: a rational approach to \u201csickest first\u201d liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl. 2007;13:30\u201337","journal-title":"Liver Transpl"},{"key":"10819_CR10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/hep.24105","volume":"53","author":"ZH Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011;53:726\u2013736","journal-title":"Hepatology"},{"key":"10819_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32\u201336","journal-title":"Hepatology"},{"key":"10819_CR12","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1016\/j.ijcard.2013.06.008","volume":"168","author":"RW Elder","year":"2013","unstructured":"Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol. 2013;168:3764\u20133769","journal-title":"Int J Cardiol"},{"key":"10819_CR13","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/modpathol.2014.79","volume":"27","author":"D-F Dai","year":"2014","unstructured":"Dai D-F, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM. Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol. 2014;27:1552\u20131558","journal-title":"Mod Pathol"},{"key":"10819_CR14","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00246-020-02291-5","volume":"41","author":"A Schleiger","year":"2020","unstructured":"Schleiger A, Salzmann M, Kramer P, Danne F, Schubert S, Bassir C, et al. Severity of fontan-associated liver disease correlates with fontan hemodynamics. Pediatr Cardiol. 2020;41:736\u2013746","journal-title":"Pediatr Cardiol"},{"key":"10819_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.amjcard.2015.11.014","volume":"117","author":"K Pundi","year":"2016","unstructured":"Pundi K, Pundi KN, Kamath PS, Cetta F, Li Z, Poterucha JT, et al. Liver disease in patients after the Fontan operation. Am J Cardiol. 2016;117:456\u2013460","journal-title":"Am J Cardiol"},{"key":"10819_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.amjcard.2014.10.032","volume":"115","author":"I Lindsay","year":"2015","unstructured":"Lindsay I, Johnson J, Everitt MD, Hoffman J, Yetman AT. Impact of liver disease after the Fontan operation. Am J Cardiol. 2015;115:249\u2013252","journal-title":"Am J Cardiol"},{"key":"10819_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijcard.2014.12.031","volume":"181","author":"SY Ofei","year":"2015","unstructured":"Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ, Zaidi AN. Liver fibrosis in adults with Fontan palliation: do common screening studies predict disease severity? Int J Cardiol. 2015;181:174\u2013175","journal-title":"Int J Cardiol"},{"key":"10819_CR18","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1007\/s00535-011-0436-4","volume":"46","author":"M Yoneda","year":"2011","unstructured":"Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, et al. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:1300\u20131306","journal-title":"J Gastroenterol"},{"key":"10819_CR19","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s11606-015-3238-1","volume":"30","author":"AR Murali","year":"2015","unstructured":"Murali AR, Attar BM, Katz A, Kotwal V, Clarke PM. Utility of platelet count for predicting cirrhosis in alcoholic liver disease: model for identifying cirrhosis in a US population. J Gen Intern Med. 2015;30:1112\u20131117","journal-title":"J Gen Intern Med"},{"key":"10819_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2007.01.015","volume":"46","author":"A Tripodi","year":"2007","unstructured":"Tripodi A, Mannucci PM. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol. 2007;46:727\u2013733","journal-title":"J Hepatol"},{"key":"10819_CR21","first-page":"3429","volume":"95","author":"J-m Pasquet","year":"2000","unstructured":"Pasquet J-m, Gross BS, Gratacap M-P, Quek L, Pasquet S, Payrastre B, et al. Thrombopoietin potentiates collagen receptor signaling in platelets through a phosphatidylinositol 3-kinase\u2013dependent pathway. Blood, J Am Soc Hematol. 2000;95:3429\u20133434","journal-title":"Blood, J Am Soc Hematol"},{"key":"10819_CR22","doi-asserted-by":"crossref","unstructured":"Mitchell O, Feldman DM, Diakow M, Sigal SH (2016) The pathophysiology of thrombocytopenia in chronic liver disease. Hepatic medicine: evidence and research, 39\u201350.","DOI":"10.2147\/HMER.S74612"},{"key":"10819_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0168-8278(02)00274-X","volume":"37","author":"E Giannini","year":"2002","unstructured":"Giannini E, Borro P, Botta F, Fumagalli A, Malfatti F, Podest\u00e0 E, et al. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis. J Hepatol. 2002;37:572\u2013577","journal-title":"J Hepatol"},{"key":"10819_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2036.2007.03512.x","volume":"26","author":"B Weksler","year":"2007","unstructured":"Weksler B. the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26:13\u201319","journal-title":"Aliment Pharmacol Ther"},{"key":"10819_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-024-03567-w","author":"M Gould","year":"2024","unstructured":"Gould M, Gunsaulus M, Feingold B, Goldstein B, Hoskoppal A, Kreutzer J, et al. Thrombocytopenia is associated with higher fontan pressure and increased morbidity in patients with fontan circulation. Pediatr Cardiol. 2024. https:\/\/doi.org\/10.1007\/s00246-024-03567-w","journal-title":"Pediatr Cardiol"},{"key":"10819_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijcard.2016.02.041","volume":"209","author":"G Agnoletti","year":"2016","unstructured":"Agnoletti G, Ferraro G, Bordese R, Marini D, Gala S, Bergamasco L, et al. Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy? Int J Cardiol. 2016;209:60\u201365","journal-title":"Int J Cardiol"},{"key":"10819_CR27","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00246-016-1428-1","volume":"37","author":"WN Evans","year":"2016","unstructured":"Evans WN, Acherman RJ, Ciccolo ML, Carrillo SA, Galindo A, Rothman A, et al. MELD-XI scores correlate with post-Fontan hepatic biopsy fibrosis scores. Pediatr Cardiol. 2016;37:1274\u20131277","journal-title":"Pediatr Cardiol"},{"key":"10819_CR28","doi-asserted-by":"publisher","first-page":"e024034","DOI":"10.1161\/JAHA.121.024034","volume":"12","author":"CE Guerrero-Chalela","year":"2023","unstructured":"Guerrero-Chalela CE, Therrien J, Grossman Y, Guo L, Liu A, Marelli A. Severe fontan associated liver disease and its association with mortality. J Am Heart Assoc. 2023;12:e024034","journal-title":"J Am Heart Assoc"},{"key":"10819_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.healun.2013.10.033","volume":"33","author":"KE Simpson","year":"2014","unstructured":"Simpson KE, Esmaeeli A, Khanna G, White F, Turnmelle Y, Eghtesady P, et al. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33:170\u2013177","journal-title":"J Heart Lung Transplant"},{"key":"10819_CR30","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2023.03.421","volume":"81","author":"MJ Lewis","year":"2023","unstructured":"Lewis MJ, Reardon LC, Aboulhosn J, Haeffele C, Chen S, Kim Y, et al. Clinical outcomes of adult fontan-associated liver disease and combined heart-liver transplantation. J Am Coll Cardiol. 2023;81:2149\u20132160","journal-title":"J Am Coll Cardiol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10819-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:41:29Z","timestamp":1771598489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10819-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10819"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10819-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}